Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro.

Oliphant K, Cochrane K, Schroeter K, Daigneault MC, Yen S, Verdu EF, Allen-Vercoe E.

mSystems. 2020 Jan 28;5(1). pii: e00404-19. doi: 10.1128/mSystems.00404-19.

2.

A survey of Fusobacterium nucleatum genes modulated by host cell infection.

Cochrane K, Robinson AV, Holt RA, Allen-Vercoe E.

Microb Genom. 2019 Oct 29. doi: 10.1099/mgen.0.000300. [Epub ahead of print]

3.

Perspectives for Consideration in the Development of Microbial Cell Reference Materials.

Allen-Vercoe E, Carmical JR, Forry SP, Gail MH, Sinha R.

Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):1949-1954. doi: 10.1158/1055-9965.EPI-19-0557. Epub 2019 Sep 12. Review.

PMID:
31515292
4.

Drivers of human gut microbial community assembly: coadaptation, determinism and stochasticity.

Oliphant K, Parreira VR, Cochrane K, Allen-Vercoe E.

ISME J. 2019 Dec;13(12):3080-3092. doi: 10.1038/s41396-019-0498-5. Epub 2019 Sep 2.

PMID:
31477821
5.

Corrigendum to "Effects of therapeutic hypothermia on the gut microbiota and metabolome of infants suffering hypoxic-ischemic encephalopathy at birth" [Int. J. Biochem. Cell Biol. 93 (December) (2017), 110-118].

Watkins C, Murphy K, Yen S, Carafa I, Dempsey EM, O' Shea CA, Allen-Vercoe E, Ross RP, Stanton C, Ryan CA.

Int J Biochem Cell Biol. 2019 Oct;115:105550. doi: 10.1016/j.biocel.2019.05.019. Epub 2019 Jun 26. No abstract available.

PMID:
31253426
6.

Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health.

Oliphant K, Allen-Vercoe E.

Microbiome. 2019 Jun 13;7(1):91. doi: 10.1186/s40168-019-0704-8. Review.

7.

Gut microbial biofilm composition and organisation holds the key to CRC.

Hold GL, Allen-Vercoe E.

Nat Rev Gastroenterol Hepatol. 2019 Jun;16(6):329-330. doi: 10.1038/s41575-019-0148-4. No abstract available.

PMID:
31040399
8.

Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children.

Paun A, Yau C, Meshkibaf S, Daigneault MC, Marandi L, Mortin-Toth S, Bar-Or A, Allen-Vercoe E, Poussier P, Danska JS.

Sci Immunol. 2019 Feb 1;4(32). pii: eaau8125. doi: 10.1126/sciimmunol.aau8125.

PMID:
30709843
9.

Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile.

Carlucci C, Jones CS, Oliphant K, Yen S, Daigneault M, Carriero C, Robinson A, Petrof EO, Weese JS, Allen-Vercoe E.

Sci Rep. 2019 Jan 29;9(1):885. doi: 10.1038/s41598-018-37547-x.

10.

Metagenomics-Based, Strain-Level Analysis of Escherichia coli From a Time-Series of Microbiome Samples From a Crohn's Disease Patient.

Fang X, Monk JM, Nurk S, Akseshina M, Zhu Q, Gemmell C, Gianetto-Hill C, Leung N, Szubin R, Sanders J, Beck PL, Li W, Sandborn WJ, Gray-Owen SD, Knight R, Allen-Vercoe E, Palsson BO, Smarr L.

Front Microbiol. 2018 Oct 30;9:2559. doi: 10.3389/fmicb.2018.02559. eCollection 2018.

11.

Phylogenetic Clustering of Genes Reveals Shared Evolutionary Trajectories and Putative Gene Functions.

Liu C, Wright B, Allen-Vercoe E, Gu H, Beiko R.

Genome Biol Evol. 2018 Sep 1;10(9):2255-2265. doi: 10.1093/gbe/evy178.

12.

Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome.

Klurfeld DM, Davis CD, Karp RW, Allen-Vercoe E, Chang EB, Chassaing B, Fahey GC Jr, Hamaker BR, Holscher HD, Lampe JW, Marette A, Martens E, O'Keefe SJ, Rose DJ, Saarela M, Schneeman BO, Slavin JL, Sonnenburg JL, Swanson KS, Wu GD, Lynch CJ.

Am J Physiol Endocrinol Metab. 2018 Dec 1;315(6):E1087-E1097. doi: 10.1152/ajpendo.00058.2018. Epub 2018 Aug 21.

13.

Using bioreactors to study the effects of drugs on the human microbiota.

Guzman-Rodriguez M, McDonald JAK, Hyde R, Allen-Vercoe E, Claud EC, Sheth PM, Petrof EO.

Methods. 2018 Oct 1;149:31-41. doi: 10.1016/j.ymeth.2018.08.003. Epub 2018 Aug 11. Review.

PMID:
30102990
14.

Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications.

Pignanelli M, Bogiatzi C, Gloor G, Allen-Vercoe E, Reid G, Urquhart BL, Ruetz KN, Velenosi TJ, Spence JD.

J Ren Nutr. 2019 Jan;29(1):55-64. doi: 10.1053/j.jrn.2018.05.007. Epub 2018 Aug 9.

PMID:
30100156
15.

Guelph Family Health Study: pilot study of a home-based obesity prevention intervention.

Haines J, Douglas S, Mirotta JA, O'Kane C, Breau R, Walton K, Krystia O, Chamoun E, Annis A, Darlington GA, Buchholz AC, Duncan AM, Vallis LA, Spriet LL, Mutch DM, Brauer P, Allen-Vercoe E, Taveras EM, Ma DWL; Guelph Family Health Study.

Can J Public Health. 2018 Aug;109(4):549-560. doi: 10.17269/s41997-018-0072-3. Epub 2018 Apr 25.

16.

Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function.

Pignanelli M, Just C, Bogiatzi C, Dinculescu V, Gloor GB, Allen-Vercoe E, Reid G, Urquhart BL, Ruetz KN, Velenosi TJ, Spence JD.

Nutrients. 2018 Jun 16;10(6). pii: E779. doi: 10.3390/nu10060779.

17.

Data on the gut and saliva microbiota from a cohort of atherosclerosis patients determined by 16S rRNA gene sequencing.

Gloor GB, Wong RG, Allen-Vercoe E, Dinculescu V, Pignanelli M, Bogiatzi C, Reid G, Spence JD.

Data Brief. 2018 May 11;19:481-485. doi: 10.1016/j.dib.2018.05.032. eCollection 2018 Aug.

18.

Metabolic products of the intestinal microbiome and extremes of atherosclerosis.

Bogiatzi C, Gloor G, Allen-Vercoe E, Reid G, Wong RG, Urquhart BL, Dinculescu V, Ruetz KN, Velenosi TJ, Pignanelli M, Spence JD.

Atherosclerosis. 2018 Jun;273:91-97. doi: 10.1016/j.atherosclerosis.2018.04.015. Epub 2018 Apr 17.

PMID:
29702430
19.

The Human Gut Microbial Metabolome Modulates Fungal Growth via the TOR Signaling Pathway.

García C, Tebbji F, Daigneault M, Liu NN, Köhler JR, Allen-Vercoe E, Sellam A.

mSphere. 2017 Dec 13;2(6). pii: e00555-17. doi: 10.1128/mSphere.00555-17. eCollection 2017 Nov-Dec.

20.

Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria.

Sessenwein JL, Baker CC, Pradhananga S, Maitland ME, Petrof EO, Allen-Vercoe E, Noordhof C, Reed DE, Vanner SJ, Lomax AE.

J Neurosci. 2017 Nov 29;37(48):11758-11768. doi: 10.1523/JNEUROSCI.1672-17.2017. Epub 2017 Oct 31.

21.

A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum.

Casasanta MA, Yoo CC, Smith HB, Duncan AJ, Cochrane K, Varano AC, Allen-Vercoe E, Slade DJ.

J Biol Chem. 2017 Dec 8;292(49):20240-20254. doi: 10.1074/jbc.M117.819144. Epub 2017 Oct 11.

22.

Towards standards for human fecal sample processing in metagenomic studies.

Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, Tramontano M, Driessen M, Hercog R, Jung FE, Kultima JR, Hayward MR, Coelho LP, Allen-Vercoe E, Bertrand L, Blaut M, Brown JRM, Carton T, Cools-Portier S, Daigneault M, Derrien M, Druesne A, de Vos WM, Finlay BB, Flint HJ, Guarner F, Hattori M, Heilig H, Luna RA, van Hylckama Vlieg J, Junick J, Klymiuk I, Langella P, Le Chatelier E, Mai V, Manichanh C, Martin JC, Mery C, Morita H, O'Toole PW, Orvain C, Patil KR, Penders J, Persson S, Pons N, Popova M, Salonen A, Saulnier D, Scott KP, Singh B, Slezak K, Veiga P, Versalovic J, Zhao L, Zoetendal EG, Ehrlich SD, Dore J, Bork P.

Nat Biotechnol. 2017 Nov;35(11):1069-1076. doi: 10.1038/nbt.3960. Epub 2017 Oct 2.

PMID:
28967887
23.

Microbial Interactions and Interventions in Colorectal Cancer.

Van Raay T, Allen-Vercoe E.

Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.BAD-0004-2016. Review.

PMID:
28643625
24.

Impact of food grade and nano-TiO2 particles on a human intestinal community.

Dudefoi W, Moniz K, Allen-Vercoe E, Ropers MH, Walker VK.

Food Chem Toxicol. 2017 Aug;106(Pt A):242-249. doi: 10.1016/j.fct.2017.05.050. Epub 2017 May 28.

25.

Corrigendum: Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice.

Belik J, Shifrin Y, Arning E, Bottiglieri T, Pan J, Daigneault MC, Allen-Vercoe E.

Sci Rep. 2017 Apr 11;7:44161. doi: 10.1038/srep44161. No abstract available.

26.

Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice.

Belik J, Shifrin Y, Arning E, Bottiglieri T, Pan J, Daigneault MC, Allen-Vercoe E.

Sci Rep. 2017 Jan 12;7:39854. doi: 10.1038/srep39854. Erratum in: Sci Rep. 2017 Apr 11;7:44161.

27.

Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.

Carlucci C, Petrof EO, Allen-Vercoe E.

EBioMedicine. 2016 Nov;13:37-45. doi: 10.1016/j.ebiom.2016.09.029. Epub 2016 Oct 1. Review.

28.

A human gut ecosystem protects against C. difficile disease by targeting TcdA.

Martz SL, Guzman-Rodriguez M, He SM, Noordhof C, Hurlbut DJ, Gloor GB, Carlucci C, Weese S, Allen-Vercoe E, Sun J, Claud EC, Petrof EO.

J Gastroenterol. 2017 Apr;52(4):452-465. doi: 10.1007/s00535-016-1232-y. Epub 2016 Jun 21.

29.

A review of the associations between single nucleotide polymorphisms in taste receptors, eating behaviors, and health.

Chamoun E, Mutch DM, Allen-Vercoe E, Buchholz AC, Duncan AM, Spriet LL, Haines J, Ma DWL; Guelph Family Health Study.

Crit Rev Food Sci Nutr. 2018 Jan 22;58(2):194-207. doi: 10.1080/10408398.2016.1152229. Epub 2017 Jul 21. Review.

PMID:
27247080
30.

Rebooting the microbiome.

Munoz S, Guzman-Rodriguez M, Sun J, Zhang YG, Noordhof C, He SM, Allen-Vercoe E, Claud EC, Petrof EO.

Gut Microbes. 2016 Jul 3;7(4):353-363. Epub 2016 May 13.

31.

Optimization of metabolomics of defined in vitro gut microbial ecosystems.

Wissenbach DK, Oliphant K, Rolle-Kampczyk U, Yen S, Höke H, Baumann S, Haange SB, Verdu EF, Allen-Vercoe E, von Bergen M.

Int J Med Microbiol. 2016 Aug;306(5):280-289. doi: 10.1016/j.ijmm.2016.03.007. Epub 2016 Mar 16. Review.

PMID:
27020116
32.

Fecal microbiota transplantation: in perspective.

Gupta S, Allen-Vercoe E, Petrof EO.

Therap Adv Gastroenterol. 2016 Mar;9(2):229-39. doi: 10.1177/1756283X15607414. Review.

33.

Using bugs as drugs: Microbial ecosystem therapeutics.

Allen-Vercoe E, Petrof EO.

Can Commun Dis Rep. 2015 Nov 19;45(Suppl 5):3-6. eCollection 2015 Nov 19.

34.

Complete genome sequences and analysis of the Fusobacterium nucleatum subspecies animalis 7-1 bacteriophage ɸFunu1 and ɸFunu2.

Cochrane K, McGuire AM, Priest ME, Abouelleil A, Cerqueira GC, Lo R, Earl AM, Allen-Vercoe E.

Anaerobe. 2016 Apr;38:125-129. doi: 10.1016/j.anaerobe.2015.10.013. Epub 2015 Nov 3.

35.

Administration of defined microbiota is protective in a murine Salmonella infection model.

Martz SL, McDonald JA, Sun J, Zhang YG, Gloor GB, Noordhof C, He SM, Gerbaba TK, Blennerhassett M, Hurlbut DJ, Allen-Vercoe E, Claud EC, Petrof EO.

Sci Rep. 2015 Nov 4;5:16094. doi: 10.1038/srep16094.

36.

Development of the faecal microbiota in foals.

Costa MC, Stämpfli HR, Allen-Vercoe E, Weese JS.

Equine Vet J. 2016 Nov;48(6):681-688. doi: 10.1111/evj.12532. Epub 2015 Dec 1.

PMID:
26518456
37.

Rarimicrobium hominis gen. nov., sp. nov., representing the fifth genus in the phylum Synergistetes that includes human clinical isolates.

Jumas-Bilak E, Bouvet P, Allen-Vercoe E, Aujoulat F, Lawson PA, Jean-Pierre H, Marchandin H.

Int J Syst Evol Microbiol. 2015 Nov;65(11):3965-3970. doi: 10.1099/ijsem.0.000520. Epub 2015 Aug 12.

PMID:
26320053
38.

Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model.

Natividad JM, Pinto-Sanchez MI, Galipeau HJ, Jury J, Jordana M, Reinisch W, Collins SM, Bercik P, Surette MG, Allen-Vercoe E, Verdu EF.

Inflamm Bowel Dis. 2015 Aug;21(8):1883-93. doi: 10.1097/MIB.0000000000000422.

PMID:
26060932
39.

Approaches to studying and manipulating the enteric microbiome to improve autism symptoms.

Frye RE, Slattery J, MacFabe DF, Allen-Vercoe E, Parker W, Rodakis J, Adams JB, Krajmalnik-Brown R, Bolte E, Kahler S, Jennings J, James J, Cerniglia CE, Midtvedt T.

Microb Ecol Health Dis. 2015 May 7;26:26878. doi: 10.3402/mehd.v26.26878. eCollection 2015.

40.

Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities.

Yen S, McDonald JA, Schroeter K, Oliphant K, Sokolenko S, Blondeel EJ, Allen-Vercoe E, Aucoin MG.

J Proteome Res. 2015 Mar 6;14(3):1472-82. doi: 10.1021/pr5011247. Epub 2015 Feb 25.

PMID:
25670064
41.

Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs.

Costa MC, Stämpfli HR, Arroyo LG, Allen-Vercoe E, Gomes RG, Weese JS.

BMC Vet Res. 2015 Feb 3;11:19. doi: 10.1186/s12917-015-0335-7.

42.

The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts.

Toh MC, Allen-Vercoe E.

Microb Ecol Health Dis. 2015 Jan 28;26:26309. doi: 10.3402/mehd.v26.26309. eCollection 2015.

43.

Simulating distal gut mucosal and luminal communities using packed-column biofilm reactors and an in vitro chemostat model.

McDonald JA, Fuentes S, Schroeter K, Heikamp-deJong I, Khursigara CM, de Vos WM, Allen-Vercoe E.

J Microbiol Methods. 2015 Jan;108:36-44. doi: 10.1016/j.mimet.2014.11.007. Epub 2014 Nov 20.

PMID:
25462016
44.

Evolution of invasion in a diverse set of Fusobacterium species.

Manson McGuire A, Cochrane K, Griggs AD, Haas BJ, Abeel T, Zeng Q, Nice JB, MacDonald H, Birren BW, Berger BW, Allen-Vercoe E, Earl AM.

mBio. 2014 Nov 4;5(6):e01864. doi: 10.1128/mBio.01864-14.

45.

Fusobacterium varium in ulcerative colitis: is it population-based?

Allen-Vercoe E.

Dig Dis Sci. 2015 Jan;60(1):7-8. doi: 10.1007/s10620-014-3390-1. Epub 2014 Oct 14. No abstract available.

PMID:
25311584
46.

Antivirulence activity of the human gut metabolome.

Antunes LC, McDonald JA, Schroeter K, Carlucci C, Ferreira RB, Wang M, Yurist-Doutsch S, Hira G, Jacobson K, Davies J, Allen-Vercoe E, Finlay BB.

mBio. 2014 Jul 29;5(4):e01183-14. doi: 10.1128/mBio.01183-14.

47.

Stability and biological activity of wild blueberry (Vaccinium angustifolium) polyphenols during simulated in vitro gastrointestinal digestion.

Correa-Betanzo J, Allen-Vercoe E, McDonald J, Schroeter K, Corredig M, Paliyath G.

Food Chem. 2014 Dec 15;165:522-31. doi: 10.1016/j.foodchem.2014.05.135. Epub 2014 Jun 4.

PMID:
25038707
48.

Fusobacterium and Enterobacteriaceae: important players for CRC?

Allen-Vercoe E, Jobin C.

Immunol Lett. 2014 Dec;162(2 Pt A):54-61. doi: 10.1016/j.imlet.2014.05.014. Epub 2014 Jun 24. Review.

49.

The microbiome: what it means for medicine.

Allen-Vercoe E, Petrof EO.

Br J Gen Pract. 2014 Mar;64(620):118-9. doi: 10.3399/bjgp14X677374. No abstract available.

50.

Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations.

Brace C, Gloor GB, Ropeleski M, Allen-Vercoe E, Petrof EO.

J Crohns Colitis. 2014 Sep;8(9):1133-7. doi: 10.1016/j.crohns.2014.01.020. Epub 2014 Feb 13. Review.

PMID:
24529606

Supplemental Content

Loading ...
Support Center